162 related articles for article (PubMed ID: 31022482)
1. NMR for sample quality assessment in metabolomics.
Ghini V; Quaglio D; Luchinat C; Turano P
N Biotechnol; 2019 Sep; 52():25-34. PubMed ID: 31022482
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Evaluation of Blood Serum and Plasma Pre-Analytics for Metabolomics Cohort Studies.
Jobard E; Trédan O; Postoly D; André F; Martin AL; Elena-Herrmann B; Boyault S
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27929400
[TBL] [Abstract][Full Text] [Related]
3. Impact of the pre-examination phase on multicenter metabolomic studies.
Ghini V; Abuja PM; Polasek O; Kozera L; Laiho P; Anton G; Zins M; Klovins J; Metspalu A; Wichmann HE; Gieger C; Luchinat C; Zatloukal K; Turano P
N Biotechnol; 2022 May; 68():37-47. PubMed ID: 35066155
[TBL] [Abstract][Full Text] [Related]
4. Quality assurance in the pre-analytical phase of human urine samples by (1)H NMR spectroscopy.
Budde K; Gök ÖN; Pietzner M; Meisinger C; Leitzmann M; Nauck M; Köttgen A; Friedrich N
Arch Biochem Biophys; 2016 Jan; 589():10-7. PubMed ID: 26264917
[TBL] [Abstract][Full Text] [Related]
5. Influence of storage conditions and extraction methods on the quantity and quality of circulating cell-free DNA (ccfDNA): the SPIDIA-DNAplas External Quality Assessment experience.
Malentacchi F; Pizzamiglio S; Verderio P; Pazzagli M; Orlando C; Ciniselli CM; Günther K; Gelmini S
Clin Chem Lab Med; 2015 Nov; 53(12):1935-42. PubMed ID: 25883202
[TBL] [Abstract][Full Text] [Related]
6. Recommendations and Best Practices for Standardizing the Pre-Analytical Processing of Blood and Urine Samples in Metabolomics.
González-Domínguez R; González-Domínguez Á; Sayago A; Fernández-Recamales Á
Metabolites; 2020 Jun; 10(6):. PubMed ID: 32503183
[TBL] [Abstract][Full Text] [Related]
7. Second SPIDIA-DNA External Quality Assessment (EQA): Influence of pre-analytical phase of blood samples on genomic DNA quality.
Malentacchi F; Pizzamiglio S; Ibrahim-Gawel H; Pazzagli M; Verderio P; Ciniselli CM; Wyrich R; Gelmini S
Clin Chim Acta; 2016 Feb; 454():10-4. PubMed ID: 26721315
[TBL] [Abstract][Full Text] [Related]
8. Metabolite Profiling of Clinical Cancer Biofluid Samples by NMR Spectroscopy.
Mickiewicz B; Hyndman ME; Vogel HJ
Methods Mol Biol; 2019; 1928():251-274. PubMed ID: 30725460
[TBL] [Abstract][Full Text] [Related]
9. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
[TBL] [Abstract][Full Text] [Related]
10. SPIDIA-RNA: first external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses.
Pazzagli M; Malentacchi F; Simi L; Orlando C; Wyrich R; Günther K; Hartmann CC; Verderio P; Pizzamiglio S; Ciniselli CM; Tichopad A; Kubista M; Gelmini S
Methods; 2013 Jan; 59(1):20-31. PubMed ID: 23110812
[TBL] [Abstract][Full Text] [Related]
11. Standard operating procedure for metabonomics studies of blood serum and plasma samples using a 1H-NMR micro-flow probe.
Sukumaran DK; Garcia E; Hua J; Tabaczynski W; Odunsi K; Andrews C; Szyperski T
Magn Reson Chem; 2009 Dec; 47 Suppl 1():S81-5. PubMed ID: 19688872
[TBL] [Abstract][Full Text] [Related]
12. Data and performances evaluation of the SPIDIA-DNA Pan-European External Quality Assessment: 2nd SPIDIA-DNA laboratory report.
Malentacchi F; Pizzamiglio S; Ibrahim-Gawel H; Pazzagli M; Verderio P; Ciniselli CM; Wyrich R; Gelmini S
Data Brief; 2016 Mar; 6():980-4. PubMed ID: 26949730
[TBL] [Abstract][Full Text] [Related]
13. Early prediction of cerebral malaria by (1)H NMR based metabolomics.
Ghosh S; Sengupta A; Sharma S; Sonawat HM
Malar J; 2016 Apr; 15():198. PubMed ID: 27066781
[TBL] [Abstract][Full Text] [Related]
14. Method validation strategies involved in non-targeted metabolomics.
Naz S; Vallejo M; García A; Barbas C
J Chromatogr A; 2014 Aug; 1353():99-105. PubMed ID: 24811151
[TBL] [Abstract][Full Text] [Related]
15. Effects of pre-analytical processes on blood samples used in metabolomics studies.
Yin P; Lehmann R; Xu G
Anal Bioanal Chem; 2015 Jul; 407(17):4879-92. PubMed ID: 25736245
[TBL] [Abstract][Full Text] [Related]
16. Influence of pre-analytical procedures on genomic DNA integrity in blood samples: the SPIDIA experience.
Malentacchi F; Ciniselli CM; Pazzagli M; Verderio P; Barraud L; Hartmann CC; Pizzamiglio S; Weisbuch S; Wyrich R; Gelmini S
Clin Chim Acta; 2015 Feb; 440():205-10. PubMed ID: 25485853
[TBL] [Abstract][Full Text] [Related]
17. NMR-based metabolomic approach to study urine samples of chronic inflammatory rheumatic disease patients.
Vignoli A; Rodio DM; Bellizzi A; Sobolev AP; Anzivino E; Mischitelli M; Tenori L; Marini F; Priori R; Scrivo R; Valesini G; Francia A; Morreale M; Ciardi MR; Iannetta M; Campanella C; Capitani D; Luchinat C; Pietropaolo V; Mannina L
Anal Bioanal Chem; 2017 Feb; 409(5):1405-1413. PubMed ID: 27900420
[TBL] [Abstract][Full Text] [Related]
18. Expanding the limits of human blood metabolite quantitation using NMR spectroscopy.
Nagana Gowda GA; Gowda YN; Raftery D
Anal Chem; 2015 Jan; 87(1):706-15. PubMed ID: 25485990
[TBL] [Abstract][Full Text] [Related]
19. Serum and urine
Wojtowicz W; Zabek A; Deja S; Dawiskiba T; Pawelka D; Glod M; Balcerzak W; Mlynarz P
Sci Rep; 2017 Aug; 7(1):9108. PubMed ID: 28831094
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
